Final Results of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial

Acute ischemic stroke is currently a major cause of disability despite improvement in recanalization therapies. Stem cells represent a promising innovative strategy focused on reduction of neurologic sequelae by enhancement of brain plasticity. We performed a phase IIa, randomized, double-blind, pla...

Descripción completa

Detalles Bibliográficos
Autores principales: de Celis-Ruiz, Elena, Fuentes, Blanca, Alonso de Leciñana, María, Gutiérrez-Fernández, María, Borobia, Alberto M., Gutiérrez-Zúñiga, Raquel, Ruiz-Ares, Gerardo, Otero-Ortega, Laura, Laso-García, Fernando, Gómez-de Frutos, Mari Carmen, Díez-Tejedor, Exuperio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943307/
https://www.ncbi.nlm.nih.gov/pubmed/35301883
http://dx.doi.org/10.1177/09636897221083863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943307/
https://www.ncbi.nlm.nih.gov/pubmed/35301883
http://dx.doi.org/10.1177/09636897221083863

Ejemplares similares